Quest Diagnostics Reports Second Quarter 2022 Financial Results; Raises Guidance for Full Year 2022

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/14/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Quest Diagnostics Reports Second Quarter 2022 Financial Results; Raises Guidance for Full Year 2022

Quest Diagnostics (DGX) Tops Q2 EPS by 12c; Raises Outlook

July 21, 2022 6:48 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $2.36, $0.12 better than the analyst estimate of $2.24. Revenue for the quarter came in at $2.45 billion versus the consensus estimate of $2.32 billion.

GUIDANCE:

Quest Diagnostics sees FY2022 EPS of $9.55-$9.95, versus the consensus of... More